Regeneron Pharmaceuticals, Inc. REGN
788.04
(7.98)
(1.00%)
as of 25 Sep
- Market cap
- $81.3B
- P/E
- 18.8×
Follow REGN
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
15.19% | 14.87% | 14.55% | 14.04% | |
| 11.80% | 11.50% | 11.28% | 10.83% | ||
ROIC |
9.14% | 8.82% | 9.20% | 9.34% | |
Return on Tangible Assets |
24.67% | 24.00% | 24.08% | 23.56% | |
Average Days of Receivables |
145.69 | 146.10 | 140.21 | 154.26 | |
Free Cash Flow per Share |
37.46 | 36.00 | 36.45 | 34.78 | |
Free Cash Flow |
3,881.00 | 3,765.20 | 3,791.00 | 3,575.20 | |
Capital Expenditures |
(1,190.00) | (1,213.70) | (1,221.70) | (1,106.10) | |
Piotroski F-Score |
4.00 | 4.00 | 4.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
12.04% | 11.70% | 11.89% | 11.23% | |
Accounts Receivable Turnover |
2.42 | 2.40 | 2.64 | 2.55 | |
Accounts Payable Turnover |
2.97 | 2.43 | 2.66 | 2.50 | |
Inventory Turnover |
0.66 | 0.67 | 0.73 | 0.75 | |
Average Days of Payables |
158.49 | 163.15 | 162.59 | 179.90 | |
Days of Inventory on Hand |
570.67 | 556.14 | 491.29 | 478.62 | |
Tax Rate |
(0.11) | (0.14) | (0.14) | (0.16) | |
Research and Development Expense of Revenue |
39.56% | 40.79% | 40.66% | 40.40% | |
Selling, General and Administrative Expense of Revenue |
19.07% | 18.82% | 18.20% | 17.65% | |
Share Based Compensation of Revenue |
7.36% | 6.93% | 6.67% | 6.35% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.11 | 1.11 | 1.13 | 1.08 | |
Depreciation/Fixed assets |
0.11 | 0.11 | 0.10 | 0.10 | |
Capex/Depreciation |
(2.27) | (2.23) | (2.26) | (2.09) | |
Revenue per Share |
137.53 | 137.12 | 143.46 | 151.12 | |
Operating CF per Share |
48.95 | 47.60 | 48.20 | 45.54 | |
Capex per Share |
(11.49) | (11.60) | (11.75) | (10.76) | |
Capex to Sales |
0.08 | 0.08 | 0.08 | 0.07 | |
Net Profit Margin |
32.13% | 31.41% | 29.65% | 27.86% |
Columns are period end dates